Roth D, Fuller L, Esquenazi V, Kyriakides G K, Pardo V, Miller J
Transplantation. 1985 Oct;40(4):376-83. doi: 10.1097/00007890-198510000-00007.
The mixed lymphocyte kidney culture (MLKC) in humans has been studied in normal and abnormal clinical conditions. Human renal cortical cells were extracted by collagenase treatment from the kidneys of "normal" heart-beating cadaver organ donors (n = 13), patients with end-stage renal disease (ESRD) at pretransplant bilateral nephrectomy and splenectomy (n = 13), and from irreversibly rejected renal allografts at the time of graft nephrectomy (n = 5). Proliferation of peripheral blood T lymphocytes of 2-DR-mismatched volunteers occurred in response to kidney cortical cells extracted from each of the 3 donor categories in a reaction termed the allogeneic mixed lymphocyte kidney culture. Additionally, splenic T cells from cadavers and patients with ESRD were seen to react to their autologous kidney cells. The renal cortical cells extracted from ESRD kidneys were more stimulatory in the allogeneic and autologous MLKC responses than those extracted from "normal" cadaver kidneys even when the ESRD kidneys were 99% depleted of passenger T and B lymphocytes by treatment with monoclonal antibodies T11 and B1. In order to help define the antigens operative in the MLKC, we pretreated stimulating lymphocytes and renal cortical cells with anti-class II monoclonal antibodies. The allogeneic mixed lymphocyte reaction and MLKC were inhibited ca. 80% and 30%, respectively. The autologous MLKC was unaffected by this treatment. To further support that tissue-specific immune mechanisms were operative in the reaction, experiments were performed with infiltrating lymphocytes isolated from the ESRD kidneys, which were seen to generate a proliferative response when stimulated with autologous cortical cells. However, the response of these same infiltrating lymphocytes when stimulated with allogeneic lymphocytes (MLR), was markedly weaker than the response of the patients' autologous spleen cells. In addition, two kidneys were obtained at rejection from recipients that had received grafts from HLA-MLR-identical sibling donors. A lymphoproliferative reaction of recipient peripheral blood T lymphocytes occurred in response to (donor) renal cortical cells, but not to donor peripheral blood lymphocytes. In contrast, infiltrating (recipient) kidney lymphocytes responded to the kidney cortical cells and to donor peripheral blood lymphocytes. Moreover, peripheral blood T lymphocytes of the HLA-identical donor responded to his own kidney cortical cells, which were isolated from the rejected recipient kidney, and did not respond to recipient peripheral blood lymphocytes. Finally, a "normal" cadaveric kidney was fortuitously available at the same time that a rejected transplant (cadaver)
人类混合淋巴细胞肾脏培养(MLKC)已在正常和异常临床情况下进行了研究。从“正常”心跳停止的尸体器官供体(n = 13)、移植前双侧肾切除术和脾切除术的终末期肾病(ESRD)患者(n = 13)以及移植肾切除术时不可逆排斥的同种异体肾移植物(n = 5)的肾脏中,通过胶原酶处理提取人肾皮质细胞。在一种称为同种异体混合淋巴细胞肾脏培养的反应中,二维DR不匹配志愿者的外周血T淋巴细胞会因从这3类供体中每一类提取的肾皮质细胞而发生增殖。此外,还观察到尸体和ESRD患者的脾T细胞对其自体肾细胞有反应。即使通过用单克隆抗体T11和B1处理使ESRD肾脏中的过客T和B淋巴细胞减少99%,从ESRD肾脏中提取的肾皮质细胞在同种异体和自体MLKC反应中仍比从“正常”尸体肾脏中提取的肾皮质细胞更具刺激性。为了帮助确定MLKC中起作用的抗原,我们用抗II类单克隆抗体预处理刺激淋巴细胞和肾皮质细胞。同种异体混合淋巴细胞反应和MLKC分别被抑制约80%和30%。自体MLKC不受该处理的影响。为了进一步支持组织特异性免疫机制在该反应中起作用,对从ESRD肾脏中分离的浸润淋巴细胞进行了实验,当用自体皮质细胞刺激时,这些淋巴细胞会产生增殖反应。然而,这些相同的浸润淋巴细胞在用同种异体淋巴细胞刺激时(混合淋巴细胞反应),其反应明显弱于患者自体脾细胞的反应。此外,从接受来自HLA混合淋巴细胞反应相同的同胞供体的移植物的受者在排斥时获得了两个肾脏。受者外周血T淋巴细胞会因(供体)肾皮质细胞而发生淋巴细胞增殖反应,但对供体外周血淋巴细胞无反应。相反,浸润的(受者)肾淋巴细胞对肾皮质细胞和供体外周血淋巴细胞有反应。此外,HLA相同供体的外周血T淋巴细胞对从被排斥的受者肾脏中分离出的其自身肾皮质细胞有反应,而对受者外周血淋巴细胞无反应。最后,在一个被排斥的移植肾(尸体肾)的同时偶然获得了一个“正常”尸体肾。